About the Authors
- Chris Fox
-
* E-mail: Chris.Fox@uea.ac.uk
Affiliation Department of Psychiatry, University of East Anglia, Norwich, United Kingdom
- Monica Crugel
-
Affiliation Old Age Psychiatry Department, Oxleas NHS Foundation Trust, London, United Kingdom
- Ian Maidment
-
Affiliation Pharmacy Research, University of Aston, Birmingham, United Kingdom
- Bjorn Henrik Auestad
-
Affiliation Department of Mathematics and Natural Sciences University of Stavanger, Stavanger, Norway
- Simon Coulton
-
Affiliation Centre for Health Service Studies, University of Kent, Kent, United Kingdom
- Adrian Treloar
-
Affiliation Old Age Psychiatry Department, Oxleas NHS Foundation Trust Memorial Hospital, London, United Kingdom
- Clive Ballard
-
Affiliation Neurodegeneration group, King’s College London, London, United Kingdom
- Malaz Boustani
-
Affiliation Indiana University Center for Aging Research, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
- Cornelius Katona
-
Affiliation Mental Health Science Unit, University College London, London, United Kingdom
- Gill Livingston
-
Affiliation Mental Health Science Unit, University College London, London, United Kingdom
Competing Interests
This work was funded by Lundbeck. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. CF has received speaker’s fees and support from Pfizer, Eisai, Novartis, Shires, and Lilly. MC was the research fellow for the MAGD study. IM has received consultancy fees and honoraria from pharmaceutical companies that include Lundbeck, Lilly, Schwarz, Pfizer, Shires, and Novartis. AT has received funding to attend educational meetings and conferences from Eisai and Pfizer and research grant from Pfizer. CB has received research grants, honoraria and consultancy fees from Lundbeck, and has received honoraria from Novartis. MB has received research funding from Forest, research funding and honoraria for advisory board membership from Novartis, and speaker’s fees and honoraria for advisory board membership from Pfizer and Eisai. CK’s institution has received research funding from Lundbeck; he has received honoraria, support for travel, lecture fees, and payment from advisory board membership from Lundbeck and Lilly and payment for preparation of educational material from Lundbeck. GL has received research funding and educational support from Lundbeck and research funding from Pfizer. SC declares no conflicts of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CF IM CK CB AT MB. Performed the experiments: MC AT CF. Analyzed the data: BA. Wrote the paper: GL CF. Contributed to the data interpretation, the drafting of the manuscript and to the final paper: GL CF IM CK CB AT MB MC SC BA.